| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/14/2013 | CA2844604A1 Pharmaceutical composition containing diamine derivative |
| 02/14/2013 | CA2844452A1 Carrier for adsorption and method for producing same |
| 02/13/2013 | EP2557086A2 Synthetic heparin pentasaccharides |
| 02/13/2013 | EP2556828A1 Composition for amelioration of hypoalbuminemia |
| 02/13/2013 | EP2556074A1 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it |
| 02/13/2013 | EP2556060A1 Substituted 3,5- diphenyl-isoxazoline derivatives as insecticides and acaricides |
| 02/13/2013 | EP2555786A1 A novel botanical formulation for treating sickle cell disease |
| 02/13/2013 | EP2555782A1 Compositions and methods for providing hematopoietic function without hla matching |
| 02/13/2013 | EP2555781A1 Compositions and methods for providing hematopoietic function |
| 02/13/2013 | EP2555762A2 System and method for the release of nitric oxide using nanoscale media |
| 02/13/2013 | CN102933705A Decellularized adipose tissue |
| 02/13/2013 | CN102933563A Substituted 3,5-di phenyl-isoxazoline derivatives as insecticides and acaricides |
| 02/13/2013 | CN102933219A Manufacturing method for polyphenol composition |
| 02/13/2013 | CN102933205A Cilostazol cocrystals and compositions |
| 02/13/2013 | CN102925422A Agkistrodon acutus hemocoagulase-B |
| 02/13/2013 | CN102924607A OGP-AcAP5 fusion protein for treating osteoporosis and thrombosis and nucleic acid for coding same |
| 02/13/2013 | CN102924606A Antitumor and thrombolytic double-effect chimeric protein of targeting tumor cell, preparation method and application thereof |
| 02/13/2013 | CN102924598A Anti-alphavbeta6 antibodies |
| 02/13/2013 | CN102924567A Peptide compound and preparation method and use of peptide compound |
| 02/13/2013 | CN102924477A New oxazine compound and application thereof |
| 02/13/2013 | CN102924476A Novel oxazine compounds and application thereof |
| 02/13/2013 | CN102924475A Novel oxazine compound and use of oxazine compound for anti-platelet aggregation |
| 02/13/2013 | CN102924457A Triazolopyrimidine derivatives, preparation method and uses thereof |
| 02/13/2013 | CN102924442A Chroman compound containing thiazole ring and analogue and medical applications thereof |
| 02/13/2013 | CN102920978A Blood nourishing and melancholy dispelling soup |
| 02/13/2013 | CN102920952A Medicine for treating child haemolytic anaemias |
| 02/13/2013 | CN102920875A Medicine for treating pretibial myxedema |
| 02/13/2013 | CN102920863A Chinese medicament for treating cerebral thrombosis and preparation method thereof |
| 02/13/2013 | CN102920862A Chinese medicinal composition for treating ascites due to cirrhosis |
| 02/13/2013 | CN102920856A Nine-ingredient stranguria-treating toxin-vanquishing decoction |
| 02/13/2013 | CN102920841A Chinese herbal medicine oral liquid |
| 02/13/2013 | CN102920839A Simiaoyongan decoction active site dry extract powder and preparation method of clinical medicinal preparation by using dry extract powder |
| 02/13/2013 | CN102920838A Simiaoyong'an decoction dry paste powder and method for preparing oral preparation by using dry paste powder |
| 02/13/2013 | CN102920836A Traditional Chinese medicine composite for treating immune thrombocytopenic purpura |
| 02/13/2013 | CN102920835A Method for processing nine-processing radix rehmanniae preparata |
| 02/13/2013 | CN102920834A Lvrong blood nourishing capsule and preparation method thereof |
| 02/13/2013 | CN102920830A Method for effectively extracting polyphenol from Longan seed |
| 02/13/2013 | CN102920789A Pharmaceutic preparation mongolian medicine Garidi for treating ulcerative colitis and preparation method of Garidi |
| 02/13/2013 | CN102920767A Preparation method of wild chrysanthemum extract |
| 02/13/2013 | CN102920738A Production method of active earthworm protein |
| 02/13/2013 | CN102920736A Preparation method of traditional Chinese medicine leech extract |
| 02/13/2013 | CN102920729A Oligomerization mannuronic acid and application of medicinal salts of oligomerization mannuronic acid in leucopenia prevention medicines |
| 02/13/2013 | CN102920690A Chemical medicine for treating cerebral-cardio vascular diseases |
| 02/13/2013 | CN102920669A Preparing method of mannitol freeze-dried powder |
| 02/13/2013 | CN102919438A Hongyan tea and method for making same |
| 02/13/2013 | CN102168062B Human pulmonary artery smooth muscle cell separation and culturing method and application of same |
| 02/13/2013 | CN101768580B Novel fibrinolysin and preparation method and use thereof |
| 02/13/2013 | CN101766573B Preparation process of clopidogrel bisulfate solid preparation |
| 02/13/2013 | CN101712676B Water soluble puerarin derivatives and preparation method and application thereof |
| 02/13/2013 | CN101371921B Instant lyophilized fibrinogen and fibrin ferment formulation composition, preparation method and use thereof |
| 02/13/2013 | CN101015353B Pure natural oxygenation health care beverage and compounding process thereof |
| 02/12/2013 | US8372837 Pyridone and pyridazone analogues as GPR119 modulators |
| 02/12/2013 | US8372800 Albumin-free factor VIII formulations |
| 02/12/2013 | US8372441 Materials and methods for preparation of alkaline earth ferrates from alkaline earth oxides, peroxides, and nitrates |
| 02/12/2013 | US8372401 Human antibodies that bind human TNFα |
| 02/12/2013 | US8372400 Methods of treating disorders using human antibodies that bind human TNFα |
| 02/12/2013 | CA2670313C Polymorphic forms of deferasirox (icl670a) |
| 02/12/2013 | CA2468892C Vitamin d analogues |
| 02/07/2013 | WO2013019857A2 Method for improving the success rate of hematopoietic stem cell transplants |
| 02/07/2013 | WO2013018837A1 Left ventricular diastolic function improving agent |
| 02/07/2013 | WO2013018695A1 Heterocyclic compound |
| 02/07/2013 | WO2013018362A1 2-acylaminothiazole compound crystals |
| 02/07/2013 | WO2013018035A1 Pharmaceutical composition comprising factor vii encapsulated in micelles |
| 02/07/2013 | WO2013017555A1 Factor vii compositions with specific glycosylation for controlled half-life |
| 02/07/2013 | WO2013017063A1 Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof |
| 02/07/2013 | WO2013016754A1 Method and formulation for inhalation |
| 02/07/2013 | US20130035389 Methods for treating myelodysplastic syndrome with ezatiostat |
| 02/07/2013 | US20130035363 Thalidomide Analogs |
| 02/07/2013 | US20130035356 Crystal of diamine derivative and method of producing same |
| 02/07/2013 | US20130035355 Prasugrel in micronized, crystalline form and pharmaceutical composition thereof |
| 02/07/2013 | US20130035333 Use of cinnabarinic acid as a modulator of immune responses in autoimmune disorders |
| 02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
| 02/07/2013 | US20130035311 Prochelators for inhibiting metal-promoted oxidative stress |
| 02/07/2013 | US20130035289 Pharmaceutical composition for treatment of thrombosis-related diseases comprising a fragment of prolactin (prl)-growth hormone (gh)-placental lactogen (pl)-family protein |
| 02/07/2013 | US20130035288 Resorption Enhancers As Additives To Improve The Oral Formulation Of Non-Anticoagulant Sulfated Polysaccharides |
| 02/07/2013 | US20130034611 Sustained preparation of factor ix |
| 02/07/2013 | US20130034552 Temperature sensitive conjugate compositions, and uses related thereto |
| 02/07/2013 | US20130034533 High Molecular Weight Derivatives of Vitamin K-Dependent Polypeptides |
| 02/07/2013 | US20130034516 Use of the modified polysaccharides for heparin neutralization |
| 02/07/2013 | CA2843240A1 Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof |
| 02/07/2013 | CA2842906A1 Left ventricular diastolic function improving agent |
| 02/07/2013 | CA2842802A1 Non-digestible capsules for the delivery of fluid absorbing materials |
| 02/06/2013 | EP2554174A1 Method for treatment of diseases |
| 02/06/2013 | EP2554173A1 Method for treatment of diseases |
| 02/06/2013 | EP2554172A1 Method for treatment of diseases |
| 02/06/2013 | EP2554171A1 Method for treatment of diseases |
| 02/06/2013 | EP2554170A1 Method for treatment of diseases |
| 02/06/2013 | EP2554161A1 Pharmaceutical composition comprising factor VII encapsulated in micelles |
| 02/06/2013 | EP2554159A1 Dosage forms comprising apixaban and content uniformity enhancer |
| 02/06/2013 | EP2552461A1 The therapeutic use of tetrathiomolybdate |
| 02/06/2013 | CN1378445B Drug releasing biodegradable fiber implant |
| 02/06/2013 | CN102918040A Purinone derivative |
| 02/06/2013 | CN102918034A Multisubstituted aromatic compounds as inhibitors of thrombin |
| 02/06/2013 | CN102917710A Esterified Polysaccharide Osmotics |
| 02/06/2013 | CN102917703A Novel EP4 agonist |
| 02/06/2013 | CN102917702A Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins |
| 02/06/2013 | CN102917691A Process for making dry and stable hemostatic compositions |
| 02/06/2013 | CN102911843A Preparation method of eclipta alba hair-blacking wine |
| 02/06/2013 | CN102911290A Method for separating and purifying heparin sodium and heparan sulfate from heparin byproducts |
| 02/06/2013 | CN102911281A Process methods for fucoidan purification from seaweed extracts |